January 20, 2022
FDA: Class I recall of Getinge Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems
Editor's Note
The Food and Drug Administration (FDA) on January 19 identified the recall by Getinge of its Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems as Class I, the most serious.
The recall was initiated because of the potential chemical breakdown of Sevoflurane that may result in inhalation and/or skin exposure to harmful chemicals.
There have been eight complaints and no reported deaths or injuries.
Distribution dates were February 16, 2021 to October 30, 2021.
Free Daily News
- Upcoming webinar covers 6 key metrics to improve OR capacity
- Third-party vendors drive healthcare cybersecurity risks
- New guidance: Preoperative GLP-1s safe for surgical patients
- Study: Beta-blockers could increase postoperative stroke risk
- Music therapy reduces opioid use, anxiety in surgical patients
- Study: Poor sleep before surgery boosts risk of postoperative delirium
- GOP-controlled Senate to prioritize drug pricing, health agency reform
- Study links nurse burnout to lower patient safety, care quality
- Private Equity fuels growth of hospital-owned ASCs amidst rising demand, regulatory loopholes
- Outpatient facilities dominate healthcare construction as demand for community-based care grows
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement